Allostery Investments’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.9K Sell
9,000
-98,141
-92% -$490K 0.57% 20
2025
Q1
$858K Buy
107,141
+33,827
+46% +$271K 1.24% 20
2024
Q4
$545K Buy
+73,314
New +$545K 0.57% 21